靶控输注丙泊酚镇静在老年ERCP患者中的安全性与有效性
该回顾性研究分析了482例在靶控输注系统下接受丙泊酚镇静的ERCP患者,按年龄分为<70岁、≥70且<85岁、≥85岁三组。结果显示年龄越大所需丙泊酚剂量越低,低血压和低氧血症发生率组间无显著差异,所有不良事件均迅速缓解,无操作中止。
要点
- 老年ERCP患者靶控输注丙泊酚镇静所需剂量随年龄增加而降低。
- 低血压和低氧血症发生率在不同年龄组间无显著差异。
- 所有不良事件均迅速缓解,无操作因不良事件中止。
核心结论
- 非麻醉医师实施的靶控输注丙泊酚镇静在老年ERCP患者中可能可接受,所需剂量低于年轻患者。
研究设计与样本
- 按年龄分为三组:A组<70岁(n=130)、B组≥70且<85岁(n=224)、C组≥85岁(n=125)。
- 比较ERCP期间丙泊酚剂量和不良事件。
主要发现
- 低血压见于23例(4.8%),组间无显著差异(A组2.3%、B组6.3%、C组4.8%;P = .24)。
- 所有不良事件均立即缓解,无操作中止。
临床怎么用
- 老年ERCP患者采用靶控输注丙泊酚镇静时,应预期所需剂量低于年轻患者。
- 非麻醉医师可在靶控输注系统下实施丙泊酚镇静,但需监测低血压和低氧血症。
局限性
- 本研究为单中心回顾性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Advanced age is an important risk factor for adverse events (AEs) during propofol sedation for endoscopic procedures. This study aimed to evaluate the safety and efficacy of nonanesthesiologist-administered propofol (NAAP) sedation with a target-controlled infusion (TCI) system in elderly patients during ERCP. METHODS: This study retrospectively analyzed 482 patients who underwent ERCP under propofol sedation with a TCI system at Iwakuni Medical Center between January 2014 and October 2016. Patients were divided into 3 groups according to their age: group A, <70 years (n = 130); group B, ≥70 and <85 years (n = 224); and group C, ≥85 years (n = 125). We compared the propofol dose and AEs during ERCP. RESULTS: The median total infusion dose and minimum and maximum target blood concentrations of propofol were 336 mg, 2.2 μg/mL, and 2.2 μg/mL in group A; 184 mg, 1.0 μg/mL, and 1.4 μg/mL in group B; and 99 mg, .6 μg/mL, and 1.0 μg/mL in group C, respectively, with older groups requiring a lower dose (P < .0001). Hypotension was observed in 23 patients (4.8%), with no significant difference between groups (group A, 2.3%; group B, 6.3%; group C, 4.8%; P = .24). Hypoxemia was observed in 16 patients (3.3%), with no significant difference between groups (group A, 3.1%; group B, 4.9%; group C, .8%; P = .17). All AEs were immediately resolved, and no procedures were aborted. CONCLUSIONS: NAAP sedation with a TCI system during ERCP may be acceptable in elderly patients with a lower dose of propofol than that used in younger patients.
引用
- Ogawa T, Tomoda T, Kato H, et al. Propofol sedation with a target-controlled infusion pump in elderly patients undergoing ERCP. Gastrointest Endosc. 2020. PMID: 32160946. doi:10.1016/j.gie.2020.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。